Tau is associated with atrophy in MCI independently of beta‐amyloid and APOE e4 genotype
Felix Carbonell, Carolann McNicoll, Alex P. Zijdenbos, Barry J Bedell. Alzheimer s & Dementia, 2025-12-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
The first SVD component accounted for 21.56%, 12.93%, 11.91% of the total co-variability between the pairs (cortical thickness, tau), (relative GM density, tau) and (absolute GM density, tau), respectively. Figures 1A, and 1B show the t-statistic maps for the effects of APOE e4 and SVD-based tau scores on cortical thickness after accounting for the beta-amyloid effects. Similarly, Figure 2A and 2B show the t-maps for the effects of the tau scores on relative and absolute GM density, respectively. We determined that the distributed tau scores showed extended areas of statistical significance with cortical thickness. Although less spatially extended, the relative and absolute GM densities also showed areas of tau-related reductions. Our results suggest that in MCI, tau is associated with consistent atrophy patterns derived from different imaging biomarkers independently of beta-amyloid burden, reflecting a significant role of tau in neurodegeneration. References 1. Carbonell et al., J. Alzheimer Dis.,73: 543-557, 2020. 2. Carbonell et al., Alzheimer and Dementia, 2025, in press.
What this study adds
Evidence grade: Low
This is a cross-sectional study of 222 participants. In this cross-sectional imaging study of people with mild cognitive impairment, tau was associated with atrophy patterns across different imaging biomarkers independently of beta-amyloid burden and APOE ε4 genotype. Reported effect size: or 21.56; 12.93%; 11.91%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Carbonell, F., McNicoll, C., Zijdenbos, A. P., & Bedell, B. J. (2025). Tau is associated with atrophy in MCI independently of beta‐amyloid and APOE e4 genotype. Alzheimer s & Dementia. https://doi.org/10.1002/alz70856_102268
Vancouver
Carbonell F, McNicoll C, Zijdenbos AP, Bedell BJ. Tau is associated with atrophy in MCI independently of beta‐amyloid and APOE e4 genotype. Alzheimer s & Dementia. 2025. doi:10.1002/alz70856_102268. PMID: 41447351.
BibTeX
@article{carbonell2025-41447351,
author = {Carbonell, Felix and McNicoll, Carolann and Zijdenbos, Alex P. and Bedell, Barry J},
title = {{Tau is associated with atrophy in MCI independently of beta‐amyloid and APOE e4 genotype}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70856_102268},
pmid = {41447351},
url = {https://doi.org/10.1002/alz70856_102268}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The first SVD component accounted for 21.56%, 12.93%, 11.91% of the total co-variability between the pairs (cortical thickness, tau), (relative GM density, tau) and (absolute GM density, tau), respectively.
- Figures 1A, and 1B show the t-statistic maps for the effects of APOE e4 and SVD-based tau scores on cortical thickness after accounting for the beta-amyloid effects.
- Similarly, Figure 2A and 2B show the t-maps for the effects of the tau scores on relative and absolute GM density, respectively.
- We determined that the distributed tau scores showed extended areas of statistical significance with cortical thickness.
- Although less spatially extended, the relative and absolute GM densities also showed areas of tau-related reductions.
Why it matters
In this cross-sectional imaging study of people with mild cognitive impairment, tau was associated with atrophy patterns across different imaging biomarkers independently of beta-amyloid burden and APOE ε4 genotype. The findings suggest tau plays a significant role in neurodegeneration in MCI.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcross-sectional
- Participants222
- Effect sizeor 21.56; 12.93%; 11.91%
- Evidence strengthLow
How this study scored 41/100
Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 39 of the 96 points we could judge it on, which is 41 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 222 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author Barry J Bedell holds only 7 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Concordia University: institution h-index 503 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41447351) |
| Free to read | 2 / 2 | Free to read |
| Points | 39 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 39 of the 96 points we could judge it on is 41 out of 100. |
| Total | 41 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70856_102268
- PubMed: 41447351
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Genetics from nearby years
Also tagged “phosphorylated”
732 studies in the library carry the topic tag “phosphorylated”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 732 tagged studies.